Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 179 | 2024 | 16715 | 4.270 |
Why?
|
HIV-1 | 94 | 2023 | 6939 | 3.280 |
Why?
|
Anti-HIV Agents | 74 | 2023 | 4255 | 3.030 |
Why?
|
Viral Load | 71 | 2024 | 3300 | 2.710 |
Why?
|
CD4 Lymphocyte Count | 69 | 2022 | 2560 | 2.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 43 | 2022 | 1872 | 2.010 |
Why?
|
RNA, Viral | 58 | 2021 | 2901 | 1.680 |
Why?
|
Anti-Retroviral Agents | 33 | 2023 | 1714 | 1.680 |
Why?
|
Viremia | 21 | 2023 | 736 | 1.650 |
Why?
|
CD8-Positive T-Lymphocytes | 27 | 2024 | 4479 | 1.500 |
Why?
|
CD4-Positive T-Lymphocytes | 44 | 2023 | 4386 | 1.490 |
Why?
|
Lymphocyte Activation | 21 | 2023 | 5524 | 1.280 |
Why?
|
HIV | 18 | 2023 | 1604 | 1.210 |
Why?
|
Acquired Immunodeficiency Syndrome | 11 | 2022 | 2232 | 1.090 |
Why?
|
Virus Latency | 11 | 2023 | 358 | 0.950 |
Why?
|
Drug Resistance, Viral | 14 | 2023 | 820 | 0.830 |
Why?
|
Proviruses | 8 | 2024 | 318 | 0.780 |
Why?
|
HIV Seropositivity | 4 | 2022 | 971 | 0.690 |
Why?
|
DNA, Viral | 13 | 2023 | 2227 | 0.680 |
Why?
|
Reverse Transcriptase Inhibitors | 10 | 2006 | 615 | 0.620 |
Why?
|
Infectious Disease Transmission, Vertical | 10 | 2016 | 1320 | 0.570 |
Why?
|
Data Interpretation, Statistical | 3 | 2015 | 2716 | 0.530 |
Why?
|
Vitamin B 12 | 5 | 2019 | 527 | 0.500 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 39 | 0.490 |
Why?
|
Models, Statistical | 5 | 2021 | 5101 | 0.480 |
Why?
|
Dietary Supplements | 12 | 2019 | 3296 | 0.460 |
Why?
|
Sarcoma, Kaposi | 3 | 2022 | 370 | 0.450 |
Why?
|
Vitamins | 9 | 2014 | 1623 | 0.440 |
Why?
|
Anthropometry | 5 | 2017 | 1350 | 0.430 |
Why?
|
Research Design | 5 | 2014 | 5984 | 0.420 |
Why?
|
Adult | 125 | 2023 | 214052 | 0.400 |
Why?
|
Benzoxazines | 7 | 2014 | 301 | 0.400 |
Why?
|
Lymphocyte Subsets | 1 | 2012 | 315 | 0.380 |
Why?
|
Bacterial Translocation | 3 | 2015 | 73 | 0.380 |
Why?
|
Monte Carlo Method | 2 | 2019 | 1254 | 0.370 |
Why?
|
Cytomegalovirus Infections | 4 | 2023 | 820 | 0.370 |
Why?
|
Withholding Treatment | 5 | 2021 | 599 | 0.370 |
Why?
|
Humans | 207 | 2024 | 744366 | 0.370 |
Why?
|
Male | 140 | 2023 | 350115 | 0.370 |
Why?
|
Vitamin B 12 Deficiency | 3 | 2016 | 116 | 0.340 |
Why?
|
Female | 139 | 2023 | 380193 | 0.340 |
Why?
|
Body Height | 2 | 2014 | 1578 | 0.330 |
Why?
|
Virus Replication | 12 | 2019 | 2535 | 0.320 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2016 | 2026 | 0.320 |
Why?
|
Lamivudine | 5 | 2016 | 342 | 0.310 |
Why?
|
Peripheral Nervous System Diseases | 4 | 2015 | 685 | 0.300 |
Why?
|
Maternal Nutritional Physiological Phenomena | 4 | 2019 | 378 | 0.300 |
Why?
|
CD4-CD8 Ratio | 4 | 2022 | 112 | 0.290 |
Why?
|
Tanzania | 16 | 2016 | 1346 | 0.290 |
Why?
|
Oxazines | 4 | 2006 | 298 | 0.290 |
Why?
|
Middle Aged | 85 | 2022 | 213390 | 0.290 |
Why?
|
Plasma | 3 | 2021 | 575 | 0.280 |
Why?
|
T-Lymphocytes | 11 | 2021 | 10183 | 0.280 |
Why?
|
Interleukin-2 | 2 | 2011 | 1904 | 0.280 |
Why?
|
Inflammation | 12 | 2023 | 10637 | 0.270 |
Why?
|
Adjuvants, Immunologic | 2 | 2011 | 1000 | 0.270 |
Why?
|
Didanosine | 4 | 2007 | 153 | 0.270 |
Why?
|
HLA-C Antigens | 3 | 2015 | 147 | 0.260 |
Why?
|
Alkynes | 7 | 2014 | 306 | 0.260 |
Why?
|
Cyclopropanes | 7 | 2014 | 416 | 0.250 |
Why?
|
Ritonavir | 3 | 2014 | 322 | 0.250 |
Why?
|
Dideoxynucleosides | 2 | 2018 | 122 | 0.250 |
Why?
|
HIV Envelope Protein gp41 | 4 | 2013 | 314 | 0.250 |
Why?
|
Valproic Acid | 4 | 2010 | 445 | 0.240 |
Why?
|
Anus Neoplasms | 2 | 2022 | 332 | 0.240 |
Why?
|
Clinical Trials Data Monitoring Committees | 1 | 2004 | 25 | 0.240 |
Why?
|
Drug Therapy, Combination | 19 | 2019 | 6489 | 0.230 |
Why?
|
Leukocytes, Mononuclear | 11 | 2020 | 1837 | 0.230 |
Why?
|
HLA-DR Antigens | 3 | 2014 | 645 | 0.230 |
Why?
|
Anemia | 4 | 2022 | 1503 | 0.230 |
Why?
|
AIDS Vaccines | 5 | 2010 | 938 | 0.230 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2016 | 657 | 0.220 |
Why?
|
Hepatitis C | 5 | 2022 | 1591 | 0.220 |
Why?
|
North America | 9 | 2022 | 1249 | 0.220 |
Why?
|
Cytomegalovirus | 3 | 2023 | 733 | 0.220 |
Why?
|
T-Lymphocyte Subsets | 4 | 2019 | 1837 | 0.220 |
Why?
|
Anemia, Iron-Deficiency | 3 | 2012 | 365 | 0.220 |
Why?
|
Pyrrolidinones | 3 | 2012 | 117 | 0.210 |
Why?
|
Histone Deacetylase Inhibitors | 6 | 2022 | 789 | 0.210 |
Why?
|
AIDS Dementia Complex | 2 | 2017 | 154 | 0.200 |
Why?
|
Micronutrients | 4 | 2016 | 375 | 0.200 |
Why?
|
Cohort Studies | 31 | 2023 | 40559 | 0.200 |
Why?
|
Treatment Outcome | 31 | 2022 | 63107 | 0.200 |
Why?
|
Hydroxamic Acids | 2 | 2014 | 494 | 0.190 |
Why?
|
Breast Feeding | 5 | 2016 | 1338 | 0.190 |
Why?
|
Drug Resistance, Multiple, Viral | 2 | 2011 | 52 | 0.190 |
Why?
|
Biomedical Research | 2 | 2014 | 3309 | 0.190 |
Why?
|
Canada | 8 | 2023 | 2065 | 0.190 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2355 | 0.180 |
Why?
|
RNA | 4 | 2023 | 2749 | 0.180 |
Why?
|
Hydroxyurea | 3 | 2007 | 289 | 0.180 |
Why?
|
HIV Antigens | 1 | 2021 | 347 | 0.180 |
Why?
|
Likelihood Functions | 3 | 2019 | 1005 | 0.180 |
Why?
|
Cognition | 5 | 2019 | 6770 | 0.180 |
Why?
|
Sputum | 2 | 2020 | 476 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2022 | 3255 | 0.180 |
Why?
|
Oropharynx | 1 | 2020 | 127 | 0.180 |
Why?
|
Virus Shedding | 3 | 2023 | 108 | 0.170 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2019 | 90 | 0.170 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2012 | 810 | 0.170 |
Why?
|
Child Development | 4 | 2019 | 2223 | 0.170 |
Why?
|
Young Adult | 33 | 2021 | 56429 | 0.170 |
Why?
|
Milk, Human | 2 | 2016 | 490 | 0.170 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 222 | 0.160 |
Why?
|
Disease Reservoirs | 3 | 2018 | 131 | 0.160 |
Why?
|
Clinical Trials as Topic | 5 | 2016 | 7914 | 0.160 |
Why?
|
Herpesvirus 3, Human | 1 | 2019 | 204 | 0.160 |
Why?
|
HIV Long-Term Survivors | 1 | 2018 | 126 | 0.150 |
Why?
|
Vitamin A | 3 | 2010 | 615 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 153 | 0.150 |
Why?
|
Double-Blind Method | 14 | 2022 | 12025 | 0.150 |
Why?
|
India | 7 | 2019 | 2197 | 0.140 |
Why?
|
Nutritional Status | 3 | 2016 | 1609 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2019 | 264 | 0.140 |
Why?
|
HIV Reverse Transcriptase | 4 | 2005 | 213 | 0.140 |
Why?
|
Longitudinal Studies | 13 | 2021 | 13991 | 0.130 |
Why?
|
Fetal Development | 2 | 2019 | 767 | 0.130 |
Why?
|
Prenatal Care | 3 | 2019 | 1092 | 0.130 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2133 | 0.130 |
Why?
|
Peptide Fragments | 5 | 2013 | 5096 | 0.130 |
Why?
|
Anticholesteremic Agents | 1 | 2022 | 979 | 0.130 |
Why?
|
Immunotherapy | 1 | 2011 | 4446 | 0.130 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2016 | 163 | 0.130 |
Why?
|
Infant, Low Birth Weight | 2 | 2017 | 850 | 0.130 |
Why?
|
HLA-A Antigens | 1 | 2015 | 232 | 0.130 |
Why?
|
Drug Administration Schedule | 8 | 2019 | 4933 | 0.130 |
Why?
|
Hair | 1 | 2018 | 481 | 0.130 |
Why?
|
Rifamycins | 1 | 2014 | 25 | 0.130 |
Why?
|
Infant | 16 | 2022 | 35134 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 1041 | 0.130 |
Why?
|
Blood | 2 | 2014 | 598 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2022 | 1381 | 0.120 |
Why?
|
Tuberculosis | 3 | 2011 | 1912 | 0.120 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 2 | 2011 | 27 | 0.120 |
Why?
|
Pregnancy | 20 | 2019 | 29144 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.120 |
Why?
|
Prospective Studies | 24 | 2020 | 53290 | 0.120 |
Why?
|
Risk Factors | 26 | 2022 | 72296 | 0.120 |
Why?
|
Membrane Glycoproteins | 3 | 2014 | 3771 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2016 | 135 | 0.120 |
Why?
|
Body Fluid Compartments | 1 | 2014 | 52 | 0.120 |
Why?
|
HIV Antibodies | 2 | 2019 | 1322 | 0.120 |
Why?
|
HLA-B Antigens | 1 | 2015 | 354 | 0.120 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2020 | 570 | 0.120 |
Why?
|
Sex Factors | 5 | 2018 | 10400 | 0.120 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2013 | 35 | 0.120 |
Why?
|
Mutation | 8 | 2023 | 29786 | 0.120 |
Why?
|
Polyamines | 1 | 2014 | 120 | 0.120 |
Why?
|
International Educational Exchange | 1 | 2014 | 50 | 0.120 |
Why?
|
Interferon-gamma | 5 | 2021 | 3207 | 0.120 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11718 | 0.120 |
Why?
|
Lymphocyte Count | 6 | 2019 | 793 | 0.110 |
Why?
|
Prevalence | 13 | 2022 | 15221 | 0.110 |
Why?
|
HIV Protease Inhibitors | 4 | 2020 | 430 | 0.110 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 498 | 0.110 |
Why?
|
Infant Mortality | 4 | 2012 | 754 | 0.110 |
Why?
|
Education, Graduate | 1 | 2014 | 81 | 0.110 |
Why?
|
Postpartum Period | 1 | 2019 | 1086 | 0.110 |
Why?
|
Chemokine CCL2 | 1 | 2015 | 619 | 0.110 |
Why?
|
Monitoring, Immunologic | 1 | 2013 | 100 | 0.110 |
Why?
|
Pregnancy Trimester, First | 2 | 2014 | 853 | 0.110 |
Why?
|
Nutritional Sciences | 1 | 2014 | 137 | 0.110 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 159 | 0.110 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 935 | 0.110 |
Why?
|
Thromboplastin | 1 | 2014 | 291 | 0.110 |
Why?
|
Phylogeny | 2 | 2023 | 2804 | 0.110 |
Why?
|
Age Factors | 5 | 2013 | 18373 | 0.100 |
Why?
|
Infant, Newborn | 12 | 2017 | 25628 | 0.100 |
Why?
|
Immunity, Cellular | 2 | 2016 | 1607 | 0.100 |
Why?
|
Aging | 4 | 2022 | 8664 | 0.100 |
Why?
|
Patient Dropouts | 1 | 2014 | 420 | 0.100 |
Why?
|
Case-Control Studies | 11 | 2020 | 21748 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2023 | 1821 | 0.100 |
Why?
|
Lactation | 1 | 2014 | 412 | 0.100 |
Why?
|
Interferon-alpha | 2 | 2013 | 895 | 0.100 |
Why?
|
Apolipoproteins | 1 | 2013 | 317 | 0.100 |
Why?
|
Iron, Dietary | 1 | 2012 | 141 | 0.100 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2017 | 2200 | 0.100 |
Why?
|
Diarrhea | 2 | 2016 | 1348 | 0.100 |
Why?
|
beta Carotene | 2 | 2010 | 527 | 0.100 |
Why?
|
Growth | 1 | 2013 | 376 | 0.100 |
Why?
|
Phosphorus | 1 | 2012 | 338 | 0.100 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 640 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2018 | 9955 | 0.090 |
Why?
|
Adolescent | 22 | 2019 | 85779 | 0.090 |
Why?
|
Nervous System | 1 | 2014 | 554 | 0.090 |
Why?
|
Dendritic Cells | 3 | 2013 | 2725 | 0.090 |
Why?
|
Caspase 8 | 1 | 2010 | 195 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1049 | 0.090 |
Why?
|
Cytokines | 4 | 2018 | 7323 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2019 | 2408 | 0.090 |
Why?
|
Incidence | 11 | 2019 | 20952 | 0.090 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2012 | 347 | 0.090 |
Why?
|
Canarypox virus | 1 | 2009 | 10 | 0.090 |
Why?
|
Aged | 24 | 2022 | 163288 | 0.090 |
Why?
|
Patient Readmission | 1 | 2023 | 3116 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 638 | 0.090 |
Why?
|
Calcium, Dietary | 1 | 2012 | 526 | 0.080 |
Why?
|
Proportional Hazards Models | 9 | 2017 | 12356 | 0.080 |
Why?
|
Antiviral Agents | 3 | 2023 | 2987 | 0.080 |
Why?
|
Enzyme Inhibitors | 4 | 2010 | 3799 | 0.080 |
Why?
|
Vaccines, DNA | 1 | 2010 | 305 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1338 | 0.080 |
Why?
|
Deoxyadenine Nucleotides | 1 | 2007 | 12 | 0.080 |
Why?
|
Vaccination | 3 | 2011 | 3279 | 0.080 |
Why?
|
Toll-Like Receptor 7 | 1 | 2009 | 172 | 0.080 |
Why?
|
Blood Coagulation | 1 | 2014 | 1127 | 0.080 |
Why?
|
Growth Disorders | 1 | 2013 | 645 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2017 | 3589 | 0.080 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2009 | 138 | 0.080 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 850 | 0.080 |
Why?
|
Follow-Up Studies | 10 | 2019 | 39052 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2019 | 2988 | 0.080 |
Why?
|
Interleukin-7 | 2 | 2005 | 142 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 2 | 2003 | 783 | 0.070 |
Why?
|
Oligopeptides | 1 | 2012 | 1189 | 0.070 |
Why?
|
Life Expectancy | 1 | 2013 | 1184 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2009 | 288 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 459 | 0.070 |
Why?
|
Delayed Diagnosis | 1 | 2010 | 441 | 0.070 |
Why?
|
United States | 15 | 2023 | 69872 | 0.070 |
Why?
|
Body Mass Index | 2 | 2016 | 12721 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2014 | 4424 | 0.070 |
Why?
|
Diet | 3 | 2013 | 7937 | 0.070 |
Why?
|
Proteinuria | 1 | 2009 | 658 | 0.070 |
Why?
|
Time Factors | 9 | 2021 | 40075 | 0.070 |
Why?
|
Socioeconomic Factors | 5 | 2019 | 7785 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3307 | 0.060 |
Why?
|
Infection Control | 1 | 2012 | 965 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1939 | 0.060 |
Why?
|
Zidovudine | 2 | 2004 | 620 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2011 | 1461 | 0.060 |
Why?
|
Thymus Gland | 2 | 2010 | 1267 | 0.060 |
Why?
|
Nylons | 1 | 2004 | 47 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12073 | 0.060 |
Why?
|
Malaria | 2 | 2012 | 1239 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12802 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 683 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2013 | 2166 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1423 | 0.060 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 112 | 0.060 |
Why?
|
Cytosol | 1 | 2007 | 901 | 0.060 |
Why?
|
Polymerase Chain Reaction | 4 | 2017 | 6171 | 0.060 |
Why?
|
Indinavir | 1 | 2004 | 74 | 0.060 |
Why?
|
Genes, MDR | 1 | 2003 | 37 | 0.060 |
Why?
|
Hemoglobins | 4 | 2013 | 1532 | 0.060 |
Why?
|
Flow Cytometry | 5 | 2019 | 5974 | 0.060 |
Why?
|
Treatment Failure | 4 | 2012 | 2618 | 0.060 |
Why?
|
Population Surveillance | 3 | 2021 | 2616 | 0.060 |
Why?
|
Iron | 1 | 2012 | 1774 | 0.060 |
Why?
|
HIV Long Terminal Repeat | 3 | 2012 | 88 | 0.060 |
Why?
|
Placebos | 2 | 2021 | 1676 | 0.060 |
Why?
|
Central Nervous System | 1 | 2011 | 1357 | 0.060 |
Why?
|
Statistics as Topic | 2 | 2007 | 2373 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2012 | 2566 | 0.060 |
Why?
|
Disease Progression | 6 | 2019 | 13286 | 0.060 |
Why?
|
Risk Assessment | 6 | 2018 | 23336 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2023 | 259 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6621 | 0.050 |
Why?
|
Genotype | 6 | 2015 | 12952 | 0.050 |
Why?
|
Survival Analysis | 5 | 2016 | 10252 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2022 | 2029 | 0.050 |
Why?
|
Comorbidity | 4 | 2021 | 10388 | 0.050 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2022 | 57 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Predictive Value of Tests | 8 | 2013 | 15078 | 0.050 |
Why?
|
Cognition Disorders | 2 | 2007 | 4043 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2017 | 6994 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2535 | 0.050 |
Why?
|
Prednisolone | 1 | 2003 | 334 | 0.050 |
Why?
|
Research Subjects | 1 | 2004 | 239 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2004 | 580 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.050 |
Why?
|
Patient Compliance | 2 | 2009 | 2684 | 0.050 |
Why?
|
Homocysteine | 2 | 2016 | 647 | 0.050 |
Why?
|
Malnutrition | 1 | 2007 | 625 | 0.050 |
Why?
|
Acute Disease | 4 | 2015 | 7147 | 0.050 |
Why?
|
Pyridines | 1 | 2012 | 2825 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.050 |
Why?
|
Cells, Cultured | 6 | 2020 | 19233 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11126 | 0.050 |
Why?
|
Heterochromatin | 1 | 2023 | 296 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13693 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4026 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2017 | 11726 | 0.040 |
Why?
|
Vomiting | 2 | 2014 | 637 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 2873 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 25039 | 0.040 |
Why?
|
Regression Analysis | 2 | 2007 | 6459 | 0.040 |
Why?
|
Serologic Tests | 1 | 2021 | 374 | 0.040 |
Why?
|
Hypertension | 2 | 2017 | 8479 | 0.040 |
Why?
|
Granzymes | 1 | 2021 | 271 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 87 | 0.040 |
Why?
|
DNA | 2 | 2024 | 7294 | 0.040 |
Why?
|
K562 Cells | 2 | 2011 | 635 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2585 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2004 | 985 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9981 | 0.040 |
Why?
|
ROC Curve | 2 | 2003 | 3528 | 0.040 |
Why?
|
Defective Viruses | 1 | 2018 | 112 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15160 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12746 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 577 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2861 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 981 | 0.040 |
Why?
|
Mothers | 3 | 2016 | 2165 | 0.040 |
Why?
|
HIV Core Protein p24 | 2 | 2010 | 256 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13104 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.040 |
Why?
|
Nonlinear Dynamics | 1 | 2020 | 502 | 0.040 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2017 | 130 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 17446 | 0.040 |
Why?
|
Postnatal Care | 1 | 2019 | 236 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3280 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2014 | 2216 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2008 | 2148 | 0.040 |
Why?
|
Phenotype | 7 | 2013 | 16367 | 0.040 |
Why?
|
Drug Hypersensitivity | 1 | 2005 | 884 | 0.030 |
Why?
|
Endpoint Determination | 2 | 2011 | 601 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7182 | 0.030 |
Why?
|
Alleles | 3 | 2015 | 6933 | 0.030 |
Why?
|
Odds Ratio | 3 | 2013 | 9849 | 0.030 |
Why?
|
Birth Weight | 2 | 2017 | 2069 | 0.030 |
Why?
|
Folic Acid | 2 | 2013 | 1300 | 0.030 |
Why?
|
DNA, Circular | 1 | 2015 | 97 | 0.030 |
Why?
|
Markov Chains | 1 | 2019 | 969 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 29060 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1379 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5953 | 0.030 |
Why?
|
Thailand | 1 | 2015 | 296 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2014 | 71 | 0.030 |
Why?
|
Neoplasms | 2 | 2021 | 21696 | 0.030 |
Why?
|
Hip | 2 | 2009 | 257 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 667 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2016 | 552 | 0.030 |
Why?
|
Cell Proliferation | 4 | 2011 | 10483 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2012 | 1793 | 0.030 |
Why?
|
Lymphocytes | 1 | 2002 | 2617 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2014 | 77460 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2012 | 1880 | 0.030 |
Why?
|
Depression | 1 | 2014 | 7759 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14723 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2019 | 847 | 0.030 |
Why?
|
Antimalarials | 2 | 2012 | 905 | 0.030 |
Why?
|
Codon | 2 | 2006 | 611 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2015 | 741 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 504 | 0.030 |
Why?
|
Avitaminosis | 1 | 2013 | 34 | 0.030 |
Why?
|
Gestational Age | 2 | 2014 | 3493 | 0.030 |
Why?
|
Chronic Disease | 4 | 2015 | 9145 | 0.030 |
Why?
|
Survivors | 1 | 2023 | 2291 | 0.030 |
Why?
|
Methylmalonic Acid | 1 | 2013 | 49 | 0.030 |
Why?
|
Language Development | 1 | 2014 | 187 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2015 | 1681 | 0.030 |
Why?
|
Algorithms | 2 | 2020 | 13882 | 0.030 |
Why?
|
Anemia, Hypochromic | 1 | 2012 | 66 | 0.030 |
Why?
|
Immunologic Memory | 2 | 2013 | 1348 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 968 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8340 | 0.030 |
Why?
|
Histones | 1 | 2022 | 2598 | 0.030 |
Why?
|
Immunodominant Epitopes | 1 | 2013 | 267 | 0.030 |
Why?
|
Fever | 2 | 2012 | 1616 | 0.030 |
Why?
|
Bangladesh | 1 | 2014 | 687 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2014 | 442 | 0.030 |
Why?
|
Safety | 1 | 2016 | 1186 | 0.030 |
Why?
|
Antigens, Fungal | 1 | 2011 | 70 | 0.020 |
Why?
|
Parasitemia | 1 | 2012 | 173 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2013 | 418 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2011 | 26 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2010 | 11 | 0.020 |
Why?
|
Immunity, Innate | 2 | 2015 | 2962 | 0.020 |
Why?
|
Urban Health | 1 | 2014 | 547 | 0.020 |
Why?
|
Gene Expression | 2 | 2015 | 7798 | 0.020 |
Why?
|
Poverty Areas | 1 | 2012 | 275 | 0.020 |
Why?
|
Virus Integration | 1 | 2013 | 299 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2307 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2010 | 82 | 0.020 |
Why?
|
Intestinal Absorption | 1 | 2012 | 420 | 0.020 |
Why?
|
History, 21st Century | 1 | 2017 | 1534 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2010 | 91 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3582 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 522 | 0.020 |
Why?
|
Receptors, KIR | 1 | 2010 | 113 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2013 | 592 | 0.020 |
Why?
|
Child, Preschool | 4 | 2016 | 41005 | 0.020 |
Why?
|
Iron Overload | 1 | 2012 | 242 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 780 | 0.020 |
Why?
|
Education, Distance | 1 | 2014 | 251 | 0.020 |
Why?
|
Saliva | 1 | 2014 | 809 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2018 | 1401 | 0.020 |
Why?
|
Parity | 1 | 2013 | 929 | 0.020 |
Why?
|
Computer Simulation | 2 | 2019 | 6194 | 0.020 |
Why?
|
Brain | 1 | 2016 | 26388 | 0.020 |
Why?
|
Ferritins | 1 | 2012 | 590 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 551 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2010 | 224 | 0.020 |
Why?
|
Multicenter Studies as Topic | 2 | 2006 | 1677 | 0.020 |
Why?
|
Plasmodium | 1 | 2012 | 250 | 0.020 |
Why?
|
Meat | 1 | 2012 | 592 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3224 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19905 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1365 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3587 | 0.020 |
Why?
|
Nutrition Policy | 1 | 2012 | 488 | 0.020 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2008 | 187 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2010 | 589 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1919 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2011 | 1035 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4751 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1856 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2009 | 724 | 0.020 |
Why?
|
Delavirdine | 1 | 2006 | 7 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3519 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2014 | 1236 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1133 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2013 | 849 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2011 | 1172 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12244 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1751 | 0.020 |
Why?
|
Child | 4 | 2019 | 77709 | 0.020 |
Why?
|
Sweating | 1 | 2005 | 123 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2006 | 667 | 0.020 |
Why?
|
HIV Fusion Inhibitors | 1 | 2005 | 81 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7730 | 0.020 |
Why?
|
Nevirapine | 1 | 2006 | 267 | 0.020 |
Why?
|
Receptors, Interleukin-7 | 1 | 2004 | 38 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.020 |
Why?
|
Progesterone | 1 | 2009 | 775 | 0.020 |
Why?
|
Demography | 1 | 2009 | 1655 | 0.020 |
Why?
|
Urban Population | 1 | 2013 | 2022 | 0.020 |
Why?
|
Injections, Intradermal | 1 | 2004 | 117 | 0.020 |
Why?
|
Energy Intake | 1 | 2012 | 2148 | 0.010 |
Why?
|
HIV Protease | 1 | 2004 | 96 | 0.010 |
Why?
|
Perceptual Disorders | 1 | 2005 | 196 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1768 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2795 | 0.010 |
Why?
|
Erythrocytes | 1 | 2013 | 2455 | 0.010 |
Why?
|
Treatment Refusal | 1 | 2006 | 421 | 0.010 |
Why?
|
Influenza Vaccines | 1 | 2011 | 738 | 0.010 |
Why?
|
Down-Regulation | 1 | 2010 | 3001 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1600 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.010 |
Why?
|
Logistic Models | 2 | 2011 | 13409 | 0.010 |
Why?
|
Virus Activation | 1 | 2004 | 319 | 0.010 |
Why?
|
Hepatitis C, Chronic | 1 | 2010 | 1031 | 0.010 |
Why?
|
Chlamydia Infections | 1 | 2005 | 365 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2012 | 2055 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4671 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6539 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2011 | 1480 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1624 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2008 | 1530 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1405 | 0.010 |
Why?
|
Gonorrhea | 1 | 2005 | 335 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 2009 | 1320 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2293 | 0.010 |
Why?
|
Vaccines, Synthetic | 1 | 2004 | 634 | 0.010 |
Why?
|
Acetylation | 1 | 2004 | 1084 | 0.010 |
Why?
|
Osteonecrosis | 1 | 2003 | 227 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1586 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13814 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9312 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6366 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3605 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3203 | 0.010 |
Why?
|
Organ Size | 1 | 2005 | 2251 | 0.010 |
Why?
|
Risk-Taking | 1 | 2006 | 986 | 0.010 |
Why?
|
Biometry | 1 | 2003 | 558 | 0.010 |
Why?
|
Crohn Disease | 1 | 2013 | 2304 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2004 | 728 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15520 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2014 | 4251 | 0.010 |
Why?
|
Body Composition | 1 | 2009 | 2402 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3778 | 0.010 |
Why?
|
HLA Antigens | 1 | 2004 | 1382 | 0.010 |
Why?
|
Area Under Curve | 1 | 2002 | 1655 | 0.010 |
Why?
|
Imidazoles | 1 | 2004 | 1206 | 0.010 |
Why?
|
Research | 1 | 2007 | 1999 | 0.010 |
Why?
|
Pyrroles | 1 | 2004 | 1146 | 0.010 |
Why?
|
Blood Glucose | 1 | 2012 | 6254 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2014 | 57776 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2887 | 0.010 |
Why?
|
Mass Screening | 1 | 2013 | 5253 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2003 | 1877 | 0.010 |
Why?
|
Antioxidants | 1 | 2005 | 1659 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9445 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8319 | 0.010 |
Why?
|
Risk | 1 | 2009 | 9688 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2951 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5749 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 4257 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16690 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7282 | 0.010 |
Why?
|
Radiography | 1 | 2003 | 7023 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15535 | 0.010 |
Why?
|
Ultrasonography | 1 | 2002 | 5984 | 0.010 |
Why?
|
Apoptosis | 1 | 2003 | 9724 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2002 | 4839 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 20130 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 35425 | 0.000 |
Why?
|